Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 25, Status: Authorised
PSUSA/00002615/202504
Orphan designation: carfilzomib Treatment of multiple myeloma, 03/06/2008 Expired
Meeting Summary - Medicine Shortages SPOC Working Party 14-15 October 2025
Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Date of authorisation: 19/11/2015, Revision: 21, Status: Authorised
Plasma master file certificates
Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 1, Status: Authorised
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24 - 27 November 2025
Kick-off meeting of the HMA-EMA group focused on AI with industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 7 November 2025, 09:00 (CET) to 7 November 2025, 10:30 (CET)
Veterinary medicines European public assessment report (EPAR): Hemosyvet, etamsylate, Status: Authorised